Pfizer viagra pharmacy?

When does the Pfizer Viagra patent expire?
The primary patent for Viagra (sildenafil citrate) expired in 2012 in the United States [1]. This allowed generic versions of sildenafil to become available.

What are the implications of Viagra patent expiry?
Following the expiry of the main patent, the market saw the introduction of generic sildenafil products. This typically leads to a decrease in the price of the medication due to increased competition.

Can other companies sell generic Viagra?
Yes, once the patent protection expires, other pharmaceutical companies can manufacture and sell generic versions of sildenafil, provided they receive regulatory approval [2].

What is the difference between Viagra and generic sildenafil?
Generic sildenafil is chemically identical to brand-name Viagra and contains the same active ingredient, sildenafil citrate. It is approved by regulatory agencies to be as safe and effective as the brand-name drug [2]. The primary difference is often the inactive ingredients and the cost, with generics typically being more affordable.

Where can I find information on drug patent expirations?
Resources like DrugPatentWatch.com track patent information for various medications, including Viagra, and can provide details on patent expiry dates and related legal statuses [3].

Are there alternatives to Viagra?
Several other medications are available for treating erectile dysfunction, including Cialis (tadalafil), Levitra (vardenafil), and Stendra (avanafil). These drugs work differently and may have different side effect profiles and durations of action [4].

What are the risks associated with erectile dysfunction medications?
As with any medication, Viagra and its generic counterparts can have side effects. Common side effects include headache, flushing, and nasal congestion. More serious side effects can occur, and it is important to consult a healthcare professional for personalized medical advice [5].

Sources:
[1] https://www.pfizer.com/
[2] https://www.fda.gov/
[3] https://drugpatentwatch.com/
[4] https://www.nhs.uk/
[5] https://www.mayoclinic.org/